HPA Axis Activity Due To Early Traumatic Stress and Metabolic Symptoms (Cort-Metab)
Primary Purpose
Childhood Trauma, Major Depressive Disorder
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
stress
Sponsored by
About this trial
This is an interventional basic science trial for Childhood Trauma
Eligibility Criteria
Inclusion Criteria:
- diagnosis of MDD and/or experience of early trauma
Exclusion Criteria:
- severe illness,
- control group: no diagnosis of MDD and experience of early trauma
Sites / Locations
- Charite University
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Experimental
Experimental
Experimental
Arm Label
Depression with early trauma
Depression without early trauma
Healthy with early trauma
Healthy without early trauma
Arm Description
stress
stress
stress
stress
Outcomes
Primary Outcome Measures
Endocrine response to stress (salivary cortisol)
salivary cortisol
glucose to oral glucose tolerance test (plasma insulin)
plasma glucose
insulin to oral glucose tolerance test (plasma insulin)
plasma insulin
cortisol to corticotropin releasing factor (salivary cortisol)
salivary cortisol
Secondary Outcome Measures
Full Information
NCT ID
NCT02398877
First Posted
March 9, 2015
Last Updated
March 4, 2016
Sponsor
Charite University, Berlin, Germany
1. Study Identification
Unique Protocol Identification Number
NCT02398877
Brief Title
HPA Axis Activity Due To Early Traumatic Stress and Metabolic Symptoms
Acronym
Cort-Metab
Official Title
Altered Hypothalamic-Pituitary-Adrenal Axis (HPA-Axis) Activity Due To Early Traumatic Stress and Its Relevance for Metabolic Symptoms
Study Type
Interventional
2. Study Status
Record Verification Date
March 2016
Overall Recruitment Status
Completed
Study Start Date
February 2013 (undefined)
Primary Completion Date
February 2016 (Actual)
Study Completion Date
February 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Charite University, Berlin, Germany
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study evaluates the association between early trauma, depression and metabolic symptoms.
Detailed Description
Early traumatic stress is associated with alterations of the hypothalamic-pituitary-adrenal axis (HPA-axis) indicated by an increased response to stress, a diminished negative feedback and alterations in expression of glucocorticoid receptors. Patients with a history of childhood trauma are more likely to develop metabolic disorders such as diabetes mellitus type 2 or metabolic syndrome.
The investigators will examine participants with and without early life stress and with and without major depression. The investigators assume that traumatized study participants (1) show an increased endocrine stress reaction to psychosocial stress, (2) display an altered sensitivity of GR, and (3) therefore suffer from an adverse cardiovascular risk profile in comparison to not-traumatized participants.
The investigators study will increase current knowledge on possible sequel of early traumatic stress. The results will lead to a more comprehensive understanding of stress-related eating behaviour and its implications.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Childhood Trauma, Major Depressive Disorder
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Non-Randomized
Enrollment
140 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Depression with early trauma
Arm Type
Experimental
Arm Description
stress
Arm Title
Depression without early trauma
Arm Type
Experimental
Arm Description
stress
Arm Title
Healthy with early trauma
Arm Type
Experimental
Arm Description
stress
Arm Title
Healthy without early trauma
Arm Type
Experimental
Arm Description
stress
Intervention Type
Other
Intervention Name(s)
stress
Primary Outcome Measure Information:
Title
Endocrine response to stress (salivary cortisol)
Description
salivary cortisol
Time Frame
2 hours
Title
glucose to oral glucose tolerance test (plasma insulin)
Description
plasma glucose
Time Frame
2 hours
Title
insulin to oral glucose tolerance test (plasma insulin)
Description
plasma insulin
Time Frame
2 hours
Title
cortisol to corticotropin releasing factor (salivary cortisol)
Description
salivary cortisol
Time Frame
3 hours
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
diagnosis of MDD and/or experience of early trauma
Exclusion Criteria:
severe illness,
control group: no diagnosis of MDD and experience of early trauma
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Katja Wingenfeld, PhD
Organizational Affiliation
Charite University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Charite University
City
Berlin
Country
Germany
12. IPD Sharing Statement
Learn more about this trial
HPA Axis Activity Due To Early Traumatic Stress and Metabolic Symptoms
We'll reach out to this number within 24 hrs